Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04623853
Other study ID # STUDY00009120
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date November 30, 2020
Est. completion date December 2024

Study information

Verified date April 2023
Source University of Washington
Contact Daniel Ballesteros, BS
Phone 206-221-5873
Email danielb25@uw.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Offloading Ankle Foot Orthoses (AFOs) are devices designed for people following lower-limb reconstruction to restore mobility by reducing mechanical loading through the injury site and redistributing it proximally. While they perform well for some users, their current form limits full functional potential and may put joints proximal to the injury at risk of long-term damage. This study is directed toward designing and testing a lightweight, variable stiffness, dynamic brace that can adjust in response to user activity.


Recruitment information / eligibility

Status Recruiting
Enrollment 22
Est. completion date December 2024
Est. primary completion date September 30, 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria (Healthy Volunteers): -able to run continuously for 1 minute Inclusion Criteria (All Other Volunteers) - prescribed an offloading Ankle-Foot Orthosis (AFO) for walking/running - Use prescribed offloading AFO at least 20 hours per week - Prescribed AFO strut length of at least 200 mm - Able to run continuously for 1 minute Exclusion Criteria (Healthy Volunteers): - limited sensation in the lower limbs - use an assistive device Exclusion Criteria (All Other Volunteers): - Unable to ambulate (walk/run) continuously with AFO for at least 1 minute - Unable to sit, stand, or negotiate a step onto lab treadmill

Study Design


Intervention

Device:
Variable Stiffness AFO
The Dynamic AFO is able to adjust in stiffness depending on activity.

Locations

Country Name City State
United States University of Washington, Dept. of Bioengineering Seattle Washington

Sponsors (2)

Lead Sponsor Collaborator
University of Washington United States Department of Defense

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Time Running Per Day Collected while participant uses device in free-living environment. Calculated across all days of data collection (up to 4 weeks).
Primary Longest Running Bout Duration Collected while participant uses device in free-living environment. Across all days of data collection (up to 4 weeks), the longest bout of continuous activity will be identified (minutes).
Primary PROMIS-Fatigue Participants will be asked to fill out a questionnaire related to their experience using the variable stiffness AFO out of lab in various test configurations. Each PROMIS-Fatigue question asks participants to rank on a scale from 1 to 5 (categorical options), with higher scores indicating a greater level of fatigue. Following their time out in their free-living environment (up to 4 weeks at a time), participants will be asked to complete a questionnaire related to fatigue.
Primary Pain Score Participants will be asked to fill out a questionnaire related to their experience using the variable stiffness AFO out of lab in various test configurations. Each Pain-Score question asks participants to rank on a scale from 1 to 10 (categorical options), with higher scores indicating a greater level of pain. Following their time out in their free-living environment (up to 4 weeks at a time), participants will be asked to complete a questionnaire related to pain.
Primary Orthotic Evaluation Questionnaire (OEQ) Similar to the Prosthesis Evaluation Questionnaire (PEQ), the OEQ will ask various questions concerning their experience wearing the variable stiffness AFO. Participants will rate their overall satisfaction, ability to ambulate, the health of their limb, the utility of the device, and their overall well-being after wearing the device. Following their time out in their free-living environment (up to 4 weeks at a time), participants will be asked to complete an OEQ.
Primary Running Speed on Treadmill Participants carrying out the in-lab protocol will be asked to run using the variable stiffness AFO and running speed will be documented at various time points. In-lab testing will occur over the course of up to 2 hours at a time.
Primary Extended Figure-of-8 Test Participants carrying out the in-lab protocol will be asked to do a Figure-of-8 test. In-lab testing wil occur over the course of up to 2 hours at a time.
See also
  Status Clinical Trial Phase
Enrolling by invitation NCT06019754 - The Anterior Approach of the Combined Lumbar and Sacral Plexuses Block for Analgesia of Lower Limb Surgeries N/A
Recruiting NCT06024798 - Detecting and Assessing Leg and Foot Stress Fractures Using Photon Counting CT
Not yet recruiting NCT05347875 - Implementation of an App-based Walking Aid Skills Training Program N/A
Completed NCT05967221 - Comparison of Postoperative Analgesia Between Intravenous Paracetamol and Intranasal Tapentadol Phase 4
Completed NCT05999890 - Comparison of Postoperative Analgesia Between Intravenous Paracetamol and Intranasal Tapentadol Phase 4
Completed NCT04675372 - Dexmedetomidine Facilitate Analgesia Phase 4
Not yet recruiting NCT05823649 - Effect of Early Versus Delayed Postoperative Feeding in Lower Limb Fracture Surgery N/A